Jennifer Cunningham
Family · Weirton, WVNPI 1265839864
Payments from drug & device makers
Across 117 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$428
- Daiichi Sankyo Inc.$198
- Novo Nordisk$189
- Mylan Specialty L.p.$139
- Lilly USA, LLC$126
- Avanir Pharmaceuticals, Inc.$121
- plus $792 from 21 others
What the payments were for
- Food & beverage$1,992100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $428 |
| Daiichi Sankyo Inc. | 11 | $198 |
| Novo Nordisk | 11 | $189 |
| Mylan Specialty L.p. | 8 | $139 |
| Lilly USA, LLC | 7 | $126 |
| Avanir Pharmaceuticals, Inc. | 8 | $121 |
| E.r. Squibb & Sons, L.L.C. | 6 | $98 |
| Pfizer | 5 | $97 |
| AstraZeneca | 5 | $77 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Novartis | 4 | $51 |
| AbbVie | 2 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Almatica Pharma LLC | 3 | $41 |
| Shield Therapeutics Inc | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $25 |
| Viatris Specialty LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| OPKO Pharmaceuticals, LLC | 1 | $15 |
| GSK | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$115
How this compares
$1,992 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $569 |
| Levothyroxine Sodium | 44 | $381 |
| Losartan Potassium | 49 | $347 |
| Pantoprazole Sodium | 18 | $264 |
| Methylprednisolone | 40 | $235 |
| Potassium Chloride | 16 | $215 |
| Glimepiride | 19 | $177 |
| Metoprolol Succinate | 13 | $148 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 25 | $129 |
| Rosuvastatin Calcium | 18 | $118 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $107 |
| Cephalexin | 32 | $102 |
| Duloxetine Hcl | 12 | $95 |
| Amlodipine Besylate | 32 | $84 |
| Azithromycin | 24 | $74 |
Paid to pharmacies, not to this prescriber.
Other family in Weirton
- Anthony ReesWeirton$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.